Swiss Life Asset Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.81M Sell
75,215
-11,989
-14% -$788K 0.02% 458
2026
Q1
$6.21M Buy
87,204
+3,823
+5% +$301K 0.03% 373
2025
Q4
$6.84M Sell
83,381
-87,502
-51% -$6.82M 0.03% 351
2025
Q3
$12.8M Buy
170,883
+89,951
+111% +$6.71M 0.07% 226
2025
Q2
$5.99M Buy
80,932
+17,572
+28% +$1.22M 0.04% 329
2025
Q1
$5.11M Buy
63,360
+8,454
+15% +$727K 0.04% 340
2024
Q4
$4.29M Buy
54,906
+46,897
+586% +$3.99M 0.03% 338
2024
Q3
$751K Buy
8,009
+911
+13% +$76.5K 0.01% 481
2024
Q2
$553K Buy
+7,098
New +$579K 0.01% 481
2024
Q1
Sell
-7,030
Closed -$544K 580
2023
Q4
$544K Buy
+7,030
New +$492K 0.01% 556

Other funds holding GEHC

Swiss Life Asset Management's GEHC Position: Q2 2026 in Review

Swiss Life Asset Management reduced its GE HealthCare (GEHC) stake by 14% in Q2 2026, selling an estimated $788K and leaving 75,215 shares worth $4.81M. The position accounts for 0.02% of the portfolio, ranked #458.

Swiss Life Asset Management first reported a position in GEHC in Q4 2023 and has held it in 10 quarters since. The position peaked at $12.8M in Q3 2025. 897 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Swiss Life Asset Management held 75,215 shares of GE HealthCare worth $4.81M as of Q2 2026.
  • Swiss Life Asset Management sold 11,989 GE HealthCare shares in Q2 2026, an estimated $788K.
  • GE HealthCare made up 0.02% of Swiss Life Asset Management's portfolio in Q2 2026, its #458 holding.
  • Swiss Life Asset Management first reported a position in GE HealthCare in Q4 2023 and has held it in 10 quarters since.
  • Swiss Life Asset Management's GE HealthCare position peaked at $12.8M in Q3 2025.
  • 897 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.